Are the implications of the diabetes control and complications trial (DCCT) feasible in daily clinical practice?

Diabetes and Metabolism

Volumn 22, Issue 6, 1996, Pages 415-419

  Gautier, J F ^a   Beressi, J P ^b   Leblanc, H ^b   Vexiau, P ^b   Passa, Ph ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE

Author keywords

daily clinical practice; DCCT; insulin dependent diabetes mellitus; intensive insulin therapy

Indexed keywords

INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATIENT MONITORING;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; MULTICENTER STUDIES;

EID: 0029850130     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Pirart J. Diabète et complications dégénératives. Présentation d'une étude prospective portant sur 4 400 cas observés entre 1947 et 1973. Diabete Metab, 1977, 97-107 and 173-182.
2. Eschwege E, Job D, Guyot-Argenton C, Aubry JP, Tchobroutsky C. Delayed progression of diabetic retinopathy by divided insulin ad-ministration : a further follow-up. Diabeiologia, 1979, 16, 13-15.
3. The Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria. N Engl J Med, 1984, 311, 365-372.
4. Lauritzen T, Larsen KF, Larsen HN, Deckert T. Steno Study Group. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes, 1985, 34, S3, 74-79.
5. Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet, 1986, ii, 1300-1304.
6. Dahl-Jorgensen K, Hanssen KF, Kierulf P, Bjoro T, Sandvik L, Agenaes O. Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. Acta Endocrinol, 1988, 117, 19-25.
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
8. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med, 1995, 332, 1251-1255.
9. Eastman RC, Corden P. The DCCT - implications for diabetes treatment. Diabetes Reviews, 1994, 2, 263-269.
10. DCCT Research Group. The Diabetes Control and Complications Trial. Design and methodologic considerations for the feasibility phase. Diabetes. 1986, 35, 530-545.
11. Diabetes Control and Complications Trial Research Group. Implementation of treatment protocols in the diabetes control and complications trial. Diabetes Care, 1995, 18, 361-376.
12. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood glucose control on late complications of type 1 diabetes. Lancet, 1993, 341, 1306-1309.
13. Microalbuminuria Collaborative Study Group. United Kingdom. Intensive therapy and progression to clinical albuminuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. BMJ, 1995, 311, 973-977.
14. Jörgens V, Grüber M, Bott U, Mühlhauser I, Berger M. Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia, 1993, 36, 99-105.
15. Hardy KJ, Jones KE, Gill GV. Deterioration in blood glucose control in females with diabetes changed to a basal-bolus regimen using a pen injector. Diabetic Medicine, 1991, 8, 69-71.
16. Mortensen HB, Villumsen J, Volund AA, Petersen KE, Nerup J and the Danish Study Group of Diabetes in Childhood. Relationship between insulin injection regimen and metabolic control in young Danish type 1 diabetic patients. Diabetic Medicine, 1992, 9. 834-839.